XORTX Therapeutics Inc (XRTX) — Financial Flexibility Index
XORTX Therapeutics Inc (XRTX) has a Financial Flexibility Index of -0.75x as of September 2025. Free cash flow of CA$-624.13K (operating CF CA$-629.62K minus capex CA$5.49K) represents -1% of total liabilities (CA$837.41K). Check XRTX capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
XORTX Therapeutics Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for XORTX Therapeutics Inc across 7 annual periods. For the full cash flow conversion analysis, see XRTX operating cash flow.
Annual Financial Flexibility Index for XORTX Therapeutics Inc (2018–2024)
Year-by-year free cash flow to debt coverage for XORTX Therapeutics Inc. Explore XORTX Therapeutics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CAD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.80x | CA$-3.64 Million | CA$-3.68 Million | CA$757.99K | ▲ +39.3% |
| 2023 | -7.91x | CA$-6.54 Million | CA$-6.58 Million | CA$825.94K | ▼ -255.8% |
| 2022 | -2.22x | CA$-11.94 Million | CA$-11.97 Million | CA$5.37 Million | ▼ -95.2% |
| 2021 | -1.14x | CA$-6.04 Million | CA$-6.06 Million | CA$5.30 Million | ▼ -67.7% |
| 2020 | -0.68x | CA$-702.62K | CA$-728.40K | CA$1.03 Million | ▼ -294.5% |
| 2019 | -0.17x | CA$-223.80K | CA$-249.58K | CA$1.30 Million | ▲ +89.3% |
| 2018 | -1.60x | CA$-1.51 Million | CA$-1.56 Million | CA$943.70K | — |